Presentation ACC 2024 ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial Presenter: C. Michael Gibson April 06, 2024 REGISTER for free or LOG IN to view this content Coronary CAD Pharma ACC 2024 Up Next Presentation ACC 2024 The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial Presenter: Gervasio A. Lamas April 07, 2024 More slides + Presentation ACC 2024 PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques Presenter: Seung-Jung Park April 07, 2024 Presentation ACC 2024 PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma? Presenter: David Austin April 08, 2024 We Recommend
Presentation ACC 2024 The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial Presenter: Gervasio A. Lamas April 07, 2024
Presentation ACC 2024 PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques Presenter: Seung-Jung Park April 07, 2024
Presentation ACC 2024 PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma? Presenter: David Austin April 08, 2024